Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Privia Health (PRVA) Shares Outstanding (Diluted Average) (2020 - 2025)

Privia Health (PRVA) has 6 years of Shares Outstanding (Diluted Average) data on record, last reported at $128.9 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 2.61% year-over-year to $128.9 million; the TTM value through Dec 2025 reached $128.9 million, up 2.61%, while the annual FY2025 figure was $128.9 million, 2.61% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $128.9 million in Q4 2025 per PRVA's latest filing, roughly flat from $128.8 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $128.9 million in Q4 2025 and bottomed at $96.0 million in Q1 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $118.5 million, with a median of $124.7 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): rose 17.89% in 2022, then dropped 0.16% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $103.0 million in 2021, then increased by 7.52% to $110.7 million in 2022, then grew by 12.64% to $124.7 million in 2023, then grew by 0.74% to $125.6 million in 2024, then increased by 2.61% to $128.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $128.9 million in Q4 2025, $128.8 million in Q3 2025, and $128.4 million in Q2 2025.